tiprankstipranks

IBRN Price & Analysis

Compare

IBRN ETF Chart & Stats

ETF Overview

iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an innovative investment vehicle designed for those looking to capitalize on the dynamic and rapidly evolving field of health care, with a specialized focus on the neuroscience and life sciences sectors. This ETF offers investors targeted exposure to companies at the forefront of pharmaceutical, biotechnology, and life sciences advancements, particularly those spearheading breakthroughs in neurological research and treatments. As a sector-focused fund, IBRN stands out for its commitment to capturing growth within the pharma, biotech, and life sciences niche, offering a diversified portfolio of firms that are pioneering in medical innovation and technology. Investors in IBRN gain access to a carefully curated selection of enterprises that are not only shaping the future of health care but are also poised to benefit from the increasing global demand for advanced neurological solutions and therapies. With its emphasis on cutting-edge research and development, the iShares Neuroscience and Healthcare ETF represents a compelling opportunity for investors seeking to align their portfolios with the next wave of health care transformation.

iShares Neuroscience and Healthcare ETF (IBRN) Fund Flow Chart

iShares Neuroscience and Healthcare ETF (IBRN) 1 year Net Flows: $0

IBRN ETF FAQ

What was IBRN’s price range in the past 12 months?
IBRN lowest ETF price was $22.66 and its highest was $28.74 in the past 12 months.
    What is the AUM of IBRN?
    As of Feb 17, 2025 The AUM of IBRN is 3.92M.
      Is IBRN overvalued?
      According to Wall Street analysts IBRN’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does IBRN pay dividends?
        IBRN pays a Semiannually dividend of $0.101 which represents an annual dividend yield of 0.39%. See more information on IBRN dividends here
          How many shares outstanding does IBRN have?
          IBRN has 150,026 shares outstanding.
            Which hedge fund is a major shareholder of IBRN?
            Currently, no hedge funds are holding shares in IBRN

            IBRN ETF Smart Score

            10
            Outperform
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10
            Learn more about TipRanks Smart Score
            For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

            Top 10 Holdings

            Name
            Weight %
            Intra-Cellular Therapies
            6.18%
            326030
            SK Biopharmaceuticals Co., Ltd.
            4.93%
            Alkermes plc
            4.67%
            ACADIA Pharmaceuticals Inc.
            4.67%
            Supernus Pharmaceuticals
            4.34%
            Catalyst Pharmaceutical Partners
            4.31%
            Argenx
            4.27%
            PTC Therapeutics
            4.22%
            Biohaven Ltd.
            3.81%
            Xenon Pharmaceuticals
            3.75%
            Total45.16%
            See All Holdings
            Popular ETFs
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis